Posted in Regulatory Lilly’s new obesity pill linked to ‘serious’ safety signals, FDA requests more data April 15, 2026 BioSpace The FDA is asking Eli Lilly to submit cardiovascular and liver safety data from an ongoing Phase 3 trial of Foundayo by July. RegulatoryMetabolic & GLP-1Read full story